(Q44149364)

30 November 2017

title

Diagnostic implications of circulating oxidized low density lipoprotein levels as a biochemical risk marker of coronary artery disease (English)

1 reference

30 November 2017

1 reference

Toru Suzuki

1

1 reference

30 November 2017

Hiroaki Kohno

2

1 reference

30 November 2017

Akira Hasegawa

3

1 reference

30 November 2017

Shunichi Toshima

4

1 reference

30 November 2017

Toshihiro Amaki

5

1 reference

30 November 2017

Masahiko Kurabayashi

6

1 reference

30 November 2017

Ryozo Nagai

7

1 reference

30 November 2017

Toru Suzuki

8

1 reference

30 November 2017

Toshihiro Amaki

9

1 reference

30 November 2017

Ryozo Nagai

10

1 reference

30 November 2017

Akira Hasegawa

11

1 reference

30 November 2017

Shunichi Toshima

12

1 reference

30 November 2017

Masa-hiko Kurabayashi

13

1 reference

30 November 2017

Kazuyuki Shimada

14

1 reference

30 November 2017

Haruo Nakamura

15

1 reference

30 November 2017

Tamio Teramoto

16

1 reference

30 November 2017

Hiroshi Yamaguchi

17

1 reference

30 November 2017

Shin-ichiro Nishiyama

18

1 reference

30 November 2017

Hakuo Takahashi

19

1 reference

30 November 2017

Ichiro Michishita

20

1 reference

30 November 2017

Zinpei Sugano

21

1 reference

30 November 2017

Keiko Konoshi

22

1 reference

30 November 2017

Clinical Trial of Oxidized LDL (CTOL) investigators

23

1 reference

30 November 2017

publication date

1 July 2002

1 reference

30 November 2017

published in

Clinical Biochemistry

1 reference

30 November 2017

volume

35

1 reference

30 November 2017

issue

5

1 reference

30 November 2017

page(s)

347-353

1 reference

Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900326-0

Role of oxidized low density lipoprotein in atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900326-0

Oxidized lipoproteins, altered cell function and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900326-0

Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900326-0

Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900326-0

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900326-0

The pathogenesis of atherosclerosis: a perspective for the 1990s

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900326-0

Role of oxidised low density lipoprotein in atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900326-0

Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900326-0

Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900326-0

Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900326-0

Simple and practical sandwich-type enzyme immunoassay for human oxidatively modified low density lipoprotein using antioxidized phosphatidylcholine monoclonal antibody and antihuman apolipoprotein-B antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900326-0

Oxidized phosphatidylcholines that modify proteins. Analysis by monoclonal antibody against oxidized low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900326-0

Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900326-0

Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900326-0

Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900326-0

Distribution of immunoreactive malondialdehyde-modified low-density lipoprotein in human serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900326-0

10.1016/S0009-9120(02)00326-0

7 January 2021

Identifiers

DOI

1 reference

30 November 2017

1 reference